tiprankstipranks
Trending News
More News >
Aptose Biosciences Inc. (APTOF)
:APTOF
US Market

Aptose Biosciences (APTOF) Stock Forecast & Price Target

Compare
1,290 Followers
See the Price Targets and Ratings of:

APTOF Financial Forecast

APTOF Earnings Forecast

Next quarter’s earnings estimate for APTOF is -$2.74 with a range of -$2.74 to -$2.74. The previous quarter’s EPS was -$2.61. APTOF beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 44.57% of the time in the same period. In the last calendar year APTOF has Outperformed its overall industry.
Next quarter’s earnings estimate for APTOF is -$2.74 with a range of -$2.74 to -$2.74. The previous quarter’s EPS was -$2.61. APTOF beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 44.57% of the time in the same period. In the last calendar year APTOF has Outperformed its overall industry.
No data currently available

APTOF Sales Forecast

Next quarter’s sales forecast for APTOF is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. APTOF beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 52.17% of the time in the same period. In the last calendar year APTOF has Preformed in-line its overall industry.
Next quarter’s sales forecast for APTOF is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. APTOF beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 52.17% of the time in the same period. In the last calendar year APTOF has Preformed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on APTOF
Joseph PantginisH.C. Wainwright
H.C. Wainwright
$2$6
Buy
450.46%
Upside
Reiterated
03/31/25
Aptose Biosciences (APTO) PT Raised to $6 at H.C. WainwrightH.C. Wainwright analyst Joseph Pantginis raised the price target on Aptose Biosciences (NASDAQ: APTO) to $6.00 (from $2.00) while maintaining a Buy rating.
Alliance Global Partners Analyst forecast on APTOF
Matthew VeneziaAlliance Global Partners
Alliance Global Partners
$12.5
Buy
1046.79%
Upside
Initiated
02/27/25
Aptose Biosciences initiated with a Speculative Buy at Alliance Global PartnersAptose Biosciences initiated with a Speculative Buy at Alliance Global Partners
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on APTOF
Joseph PantginisH.C. Wainwright
H.C. Wainwright
$2$6
Buy
450.46%
Upside
Reiterated
03/31/25
Aptose Biosciences (APTO) PT Raised to $6 at H.C. WainwrightH.C. Wainwright analyst Joseph Pantginis raised the price target on Aptose Biosciences (NASDAQ: APTO) to $6.00 (from $2.00) while maintaining a Buy rating.
Alliance Global Partners Analyst forecast on APTOF
Matthew VeneziaAlliance Global Partners
Alliance Global Partners
$12.5
Buy
1046.79%
Upside
Initiated
02/27/25
Aptose Biosciences initiated with a Speculative Buy at Alliance Global PartnersAptose Biosciences initiated with a Speculative Buy at Alliance Global Partners
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Aptose Biosciences

1 Month
xxx
Success Rate
2/7 ratings generated profit
29%
Average Return
-14.67%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 28.57% of your transactions generating a profit, with an average return of -14.67% per trade.
3 Months
xxx
Success Rate
0/7 ratings generated profit
0%
Average Return
-57.51%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -57.51% per trade.
1 Year
Joseph PantginisH.C. Wainwright
Not Ranked
Success Rate
0/7 ratings generated profit
0%
Average Return
-86.73%
reiterated a buy rating 3 months ago
Copying Joseph Pantginis's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -86.73% per trade.
2 Years
xxx
Success Rate
0/7 ratings generated profit
0%
Average Return
-88.10%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -88.10% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

APTOF Analyst Recommendation Trends

Rating
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Strong Buy
3
3
4
5
5
Buy
0
0
0
0
0
Hold
1
1
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
4
4
5
5
In the current month, APTOF has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. APTOF average Analyst price target in the past 3 months is 6.00.
Each month's total comprises the sum of three months' worth of ratings.

APTOF Stock Forecast FAQ

What is APTOF’s average 12-month price target, according to analysts?
Based on analyst ratings, Aptose Biosciences Inc.’s 12-month average price target is 6.00.
    What is APTOF’s upside potential, based on the analysts’ average price target?
    Aptose Biosciences Inc. has 450.46% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is APTOF a Buy, Sell or Hold?
          Aptose Biosciences Inc. has a consensus rating of Moderate Buy which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Aptose Biosciences Inc.’s price target?
            The average price target for Aptose Biosciences Inc. is 6.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $6.00 ,the lowest forecast is $6.00. The average price target represents 450.46% Increase from the current price of $1.09.
              What do analysts say about Aptose Biosciences Inc.?
              Aptose Biosciences Inc.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
                How can I buy shares of APTOF?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis